enVVeno Medical Corp Operating Cash Flow
enVVeno Medical Corp (NVNO) reported Operating Cash Flow of -$6.79 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-30
- enVVeno Medical Corp net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.55M.
- enVVeno Medical Corp net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$3.24M.
- enVVeno Medical Corp net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.44M.
- enVVeno Medical Corp net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$4.39M.
- enVVeno Medical Corp net cash provided by (used in) operating activities for fiscal 2025 was -$15.57M.
- enVVeno Medical Corp net cash provided by (used in) operating activities for fiscal 2024 was -$16.84M.
- enVVeno Medical Corp net cash provided by (used in) operating activities for fiscal 2023 was -$18.86M.
- enVVeno Medical Corp net cash provided by (used in) operating activities for fiscal 2022 was -$15.62M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$6.79M 10-Q · filed 2026-07-30 | -$10.23M derived: sum of 3 quarters · filed 2026-07-30 | -$14.62M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$3.24M 10-Q · filed 2026-05-06 | -$6.68M derived: sum of 2 quarters · filed 2026-05-06 | -$11.07M derived: sum of 3 quarters · filed 2026-05-06 | -$14.79M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$7.83M derived: sum of 2 quarters · filed 2026-03-26 | -$11.55M derived: sum of 3 quarters · filed 2026-07-30 | -$15.57M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$4.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$8.11M derived: sum of 2 quarters · filed 2026-07-30 | -$12.13M 10-Q · filed 2025-10-30 | -$17.23M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$7.73M 10-Q · filed 2026-07-30 | -$12.84M derived: sum of 3 quarters · filed 2026-07-30 | -$17.11M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$4.02M 10-Q · filed 2026-05-06 | -$9.12M derived: sum of 2 quarters · filed 2026-05-06 | -$13.40M derived: sum of 3 quarters · filed 2026-05-06 | -$17.31M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$5.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$9.38M derived: sum of 2 quarters · filed 2026-03-26 | -$13.29M derived: sum of 3 quarters · filed 2026-03-26 | -$16.84M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$8.18M derived: sum of 2 quarters · filed 2025-10-30 | -$11.73M 10-Q · filed 2025-10-30 | -$16.71M derived: sum of 4 quarters · filed 2025-10-30 | ||||
| 2024-06-30 | -$3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$7.46M 10-Q · filed 2025-07-31 | -$12.43M derived: sum of 3 quarters · filed 2025-07-31 | -$16.64M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-03-31 | -$3.55M 10-Q · filed 2025-04-30 | -$3.55M 10-Q · filed 2024-05-08 | -$8.52M derived: sum of 2 quarters · filed 2025-04-30 | -$12.74M derived: sum of 3 quarters · filed 2025-04-30 | -$17.30M derived: sum of 4 quarters · filed 2025-04-30 | |||
| 2023-12-31 | -$4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$9.19M derived: sum of 2 quarters · filed 2025-02-28 | -$13.75M derived: sum of 3 quarters · filed 2025-02-28 | -$18.86M 10-K · filed 2025-02-28 | ||||
| 2023-09-30 | -$4.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$8.78M derived: sum of 2 quarters · filed 2024-10-31 | -$13.88M 10-Q · filed 2024-10-31 | -$17.74M derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | -$4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$9.67M 10-Q · filed 2024-07-31 | -$13.53M derived: sum of 3 quarters · filed 2024-07-31 | -$18.01M derived: sum of 4 quarters · filed 2024-07-31 | ||||
| 2023-03-31 | -$5.11M 10-Q · filed 2024-05-08 | -$8.96M derived: sum of 2 quarters · filed 2024-05-08 | -$13.45M derived: sum of 3 quarters · filed 2024-05-08 | -$17.41M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | -$3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$8.34M derived: sum of 2 quarters · filed 2024-02-29 | -$12.30M derived: sum of 3 quarters · filed 2024-02-29 | -$15.62M 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | -$4.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$8.44M derived: sum of 2 quarters · filed 2023-10-26 | -$11.76M 10-Q · filed 2023-10-26 | -$14.87M derived: sum of 4 quarters · filed 2023-10-26 | ||||
| 2022-06-30 | -$3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | -$7.28M 10-Q · filed 2023-07-31 | -$10.38M derived: sum of 3 quarters · filed 2023-07-31 | -$12.62M derived: sum of 4 quarters · filed 2023-07-31 | ||||
| 2022-03-31 | -$3.32M 10-Q · filed 2023-04-28 | -$6.42M derived: sum of 2 quarters · filed 2023-04-28 | -$8.66M derived: sum of 3 quarters · filed 2023-04-28 | -$11.33M derived: sum of 4 quarters · filed 2023-04-28 | ||||
| 2021-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$5.33M derived: sum of 2 quarters · filed 2023-03-02 | -$8.01M derived: sum of 3 quarters · filed 2023-03-02 | -$11.85M 10-K · filed 2023-03-02 | -$11.85M 10-K · filed 2022-03-28 | |||
| 2021-09-30 | -$2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$4.90M derived: sum of 2 quarters · filed 2022-10-27 | -$8.75M 10-Q · filed 2022-10-27 | -$8.75M 10-Q · filed 2021-11-12 | -$11.36M derived: sum of 4 quarters · filed 2022-10-27 | |||
| 2021-06-30 | -$2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$6.51M 10-Q · filed 2022-08-03 | -$6.51M 10-Q · filed 2021-08-11 | -$9.13M derived: sum of 3 quarters · filed 2022-08-03 | -$11.72M derived: sum of 4 quarters · filed 2022-08-03 | |||
| 2021-03-31 | -$3.84M 10-Q · filed 2022-04-29 | -$3.84M 10-Q · filed 2021-05-12 | -$6.46M derived: sum of 2 quarters · filed 2022-04-29 | -$9.05M derived: sum of 3 quarters · filed 2022-04-29 | -$10.37M derived: sum of 4 quarters · filed 2022-04-29 | |||
| 2020-12-31 | -$2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$5.21M derived: sum of 2 quarters · filed 2022-03-28 | -$6.53M derived: sum of 3 quarters · filed 2022-03-28 | -$7.68M 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | -$2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$3.91M derived: sum of 2 quarters · filed 2021-11-12 | -$5.06M 10-Q · filed 2021-11-12 | -$6.69M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$2.47M 10-Q · filed 2021-08-11 | -$4.10M derived: sum of 3 quarters · filed 2021-08-11 | -$5.45M derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | -$1.15M 10-Q · filed 2021-05-12 | -$2.78M derived: sum of 2 quarters · filed 2021-05-12 | -$4.13M derived: sum of 3 quarters · filed 2021-05-12 | -$5.55M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$2.97M derived: sum of 2 quarters · filed 2021-03-31 | -$4.40M derived: sum of 3 quarters · filed 2021-03-31 | -$5.90M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | -$2.78M derived: sum of 2 quarters · filed 2020-11-17 | -$4.27M 10-Q · filed 2020-11-17 | -$5.72M derived: sum of 4 quarters · filed 2020-11-17 | ||||
| 2019-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$2.92M 10-Q · filed 2020-08-14 | -$4.37M derived: sum of 3 quarters · filed 2020-08-14 | -$6.11M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$1.49M 10-Q · filed 2020-06-08 | -$2.94M derived: sum of 2 quarters · filed 2020-06-08 | -$4.68M derived: sum of 3 quarters · filed 2020-06-08 | -$6.22M derived: sum of 4 quarters · filed 2020-06-08 | ||||
| 2018-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-18 | -$3.19M derived: sum of 2 quarters · filed 2020-03-18 | -$4.73M derived: sum of 3 quarters · filed 2020-03-18 | -$6.36M 10-K · filed 2020-03-18 | ||||
| 2018-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$3.29M derived: sum of 2 quarters · filed 2019-10-31 | -$4.91M 10-Q · filed 2019-10-31 | -$6.18M derived: sum of 4 quarters · filed 2019-10-31 | ||||
| 2018-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$3.17M 10-Q · filed 2019-08-05 | -$4.44M derived: sum of 3 quarters · filed 2019-08-05 | -$5.65M derived: sum of 4 quarters · filed 2019-08-05 | ||||
| 2018-03-31 | -$1.63M 10-Q · filed 2019-05-09 | -$2.90M derived: sum of 2 quarters · filed 2019-05-09 | -$4.11M derived: sum of 3 quarters · filed 2019-05-09 | |||||
| 2017-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$2.48M derived: sum of 2 quarters · filed 2019-03-14 | -$4.20M 10-K · filed 2019-03-14 | |||||
| 2017-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$2.93M 10-Q · filed 2018-11-07 | ||||||
| 2017-06-30 | -$1.72M 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |